Who does this study affect? People with castration-resistant metastatic prostate cancer (mCRPC) with or without homologous recombination repair (HRR) gene alterations. What did this study find? The ...
Confirm that they can objectively measure the tumor by physical or radiographic exam per RECIST v1.1. Review the patient’s molecular test from a CLIA-certified and CAP-accredited or New York ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback